Issue 2

Kidney

Newsletter

Keeping you up to date with the latest exciting advances and discussions in nephrology

Issue 1 - in focus

See below to revisit the Issue 1 ‘In focus’ section

  • Clinical challenges in kidney disease management
  • What are the barriers to optimising clinical care across the CKD continuum?
CKD-MBD Read more
CKD-aP Read more
AAV Read more

Images are not of real patients

Vifor Pharma’s commitment to nephrology

Want to learn more about Vifor Pharma’s Nephrology Portfolio?

This video, first shown at the 58th ERA-EDTA Congress (5–8 June 2021), highlights how Vifor Pharma strives to improve the lives of people suffering from conditions affecting their kidneys, through a broad, innovative nephrology portfolio and individualised solutions.

thumb
References and footnotes

FOOTNOTES

AAV, anti-neutrophil cytoplasmic auto-antibody-associated vasculitis; CKD, chronic kidney disease; CKD-aP, chronic kidney disease-associated pruritus; CKD-MBD, chronic kidney disease-mineral bone disorder.

You are now heading to a third-party website that we do
not operate. We are not responsible for the content of the
third-party website. You are advised to review its privacy policy
as it may differ from ours.

 

Are you sure you want to leave?

Confirm

Cancel